William P. Petros

Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release.

Garheng Kong, Gopal Anyarambhatla, William P. Petros et al. · PubMed · 2000 · 508 citations

Pharmacy, Oncology, Pharmacology +17

A phase I pharmacokinetic and translational study of the novel vascular targeting agent combretastatin a-4 phosphate on a single-dose intravenous schedule in patients with advanced cancer.

Afshin Dowlati, Kelly M. Robertson, Matthew M. Cooney et al. · PubMed · 2002 · 406 citations

Medicine, Oncology, Pharmacology +17

Irinotecan Therapy in Adults With Recurrent or Progressive Malignant Glioma

Henry S. Friedman, William P. Petros, Allan H. Friedman et al. · Journal of Clinical Oncology · 1999 · 355 citations · Full text

Medicine, Oncology, Pharmacology +13

Transforming Growth Factor β as a Predictor of Liver and Lung Fibrosis after Autologous Bone Marrow Transplantation for Advanced Breast Cancer

Mitchell S. Anscher, William P. Peters, Herbert Reisenbichler et al. · New England Journal of Medicine · 1993 · 315 citations · Full text

Medicine, Oncology, Pathobiology +11

Phase I Trial of the Antivascular Agent Combretastatin A4 Phosphate on a 5-Day Schedule to Patients With Cancer: Magnetic Resonance Imaging Evidence for Altered Tumor Blood Flow

James Stevenson, Mark Rosen, Weijing Sun et al. · Journal of Clinical Oncology · 2003 · 293 citations

Medicine, Oncology, Pharmacology +17